Dr Amesh Adalja, a professor at the Johns Hopkins Bloomberg school of public health, told DailyMail.com that one disease ...

EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

New research led by scientists at La Jolla Institute for Immunology reveals the workings of a human antibody called mAb 3A6, ...